Niki BioSolutions NIKI Growth Metrics (2018-2025)

NASDAQ NIKI
$1.93 -0.10 (-4.81%)
As of: Oct 21, 2026 · 3:59 PM EDT
Reported Financials

Niki BioSolutions Quarterly Growth Metrics

Periods 15 quarters
Latest Nov 2025

Niki BioSolutions growth metrics data for the quarter ended Nov 2025. These growth metrics cover 15 quarters of results from Dec 2018 through Nov 2025, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Dec2018 Dec2019 Jun2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Aug2024 Nov2024 May2025 Aug2025 Nov2025
Growth Ratios
Assets Growth (1y) 42.82%-46.86%-5.79%84.65%36.06%-50.47%-24.27%-4.75%-40.00%-1.09%-33.67%
Assets Growth (3y) 11.91%-21.38%-0.98%-4.49%-14.81%-22.44%
Assets Growth (5y) -7.94%-14.46%
Assets (QoQ) 6.78%17.13%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) 56.09%-79.73%-7.68%-31.51%386.63%127.88%-64.14%-39.32%-95.27%-60.00%-19.12%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y) -39.93%-31.86%17.23%-1.80%-56.46%-17.91%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y) -21.41%-40.15%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) -50.18%199.83%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y) -183.38%
Cash from Operations (QoQ)Cash from Ops. (QoQ) -40.90%
EBIT Growth (1y) -282.93%
EBIT Margin (QoQ) 0.00M
EBIT (QoQ) 44.89%
EBT Growth (1y) -253.63%
EBT Margin (QoQ) 0.00M
EBT (QoQ) 40.45%
EPS (Basic) Growth (1y) -33.44%
EPS (Basic) (QoQ) 39.72%
EPS (Diluted) Growth (1y) -33.44%
EPS (Diluted) (QoQ) 39.72%
FCF Margin (QoQ) -747.00
Free Cash Flow Growth (1y)FCF Growth (1y) -183.38%
Free Cash Flow (QoQ)FCF (QoQ) -40.90%
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y) -182.40%
Net Cash Flow Growth (1y)NCF Growth (1y) -172.30%
Net Cash Flow (QoQ)NCF (QoQ) 165.86%-62.77%
Net Income Growth (1y) -60.94%
Net Income (QoQ) 39.72%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) -60.94%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ) 39.72%
Net Margin (QoQ) 0.00M
Operating Income Growth (1y)Op. Inc Growth (1y) -282.93%
Operating Income (QoQ)Op. Inc (QoQ) 44.89%
Operating Margin (QoQ) 0.00M
Profit After Tax Growth (1y)PAT Growth (1y) -241.54%
Profit After Tax (QoQ)PAT (QoQ) 39.72%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) 1,129.30%66.48%6.28%-33.93%-32.44%-20.38%-19.69%-24.28%-34.26%-41.10%-50.98%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y) 138.24%-4.33%-16.77%-26.42%-29.08%-29.19%
Property, Plant & Equipment (Net) Growth (5y)PP&E (Net) Growth (5y) 52.14%-17.14%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ) 10.07%-22.00%
Return on Sales [ROS] (QoQ)ROS (QoQ) 0.00M
Revenue (QoQ) 12.03%
Share-based Compensation (QoQ)Stock Comp. (QoQ) -59.93%
Total Debt Growth (1y) 1,897.89%-53.22%65,770.10%-68.29%-52.52%-99.43%173.11%30,631.41%-97.19%-97.74%
Total Debt Growth (3y) 43.63%-90.56%848.84%-17.93%-66.83%-65.96%
Total Debt Growth (5y) 38.88%-64.24%

Niki BioSolutions Growth Metrics API

Pull Niki BioSolutions's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=NIKI&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY